Login / Signup

The another side of COVID-19 in Alzheimer's disease patients: Drug-drug interactions.

Fatma Nisa Balli TurhanEmre KaraKutay Demirkan
Published in: International journal of clinical practice (2020)
Keyphrases
  • end stage renal disease
  • coronavirus disease
  • ejection fraction
  • sars cov
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • cognitive decline
  • patient reported outcomes